Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 118

1.

Normal triglyceride levels and coronary artery disease events: the Baltimore Coronary Observational Long-Term Study.

Miller M, Seidler A, Moalemi A, Pearson TA.

J Am Coll Cardiol. 1998 May;31(6):1252-7.

PMID:
9581716
[PubMed - indexed for MEDLINE]
Free Article
2.

Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study.

Downs JR, Clearfield M, Weis S, Whitney E, Shapiro DR, Beere PA, Langendorfer A, Stein EA, Kruyer W, Gotto AM Jr.

JAMA. 1998 May 27;279(20):1615-22.

PMID:
9613910
[PubMed - indexed for MEDLINE]
3.

Long-term predictors of subsequent cardiovascular events with coronary artery disease and 'desirable' levels of plasma total cholesterol.

Miller M, Seidler A, Kwiterovich PO, Pearson TA.

Circulation. 1992 Oct;86(4):1165-70.

PMID:
1394924
[PubMed - indexed for MEDLINE]
4.

Prognostic value of remnant-like lipoprotein particle levels in patients with coronary artery disease and type II diabetes mellitus.

Fukushima H, Sugiyama S, Honda O, Koide S, Nakamura S, Sakamoto T, Yoshimura M, Ogawa H, Fujioka D, Kugiyama K.

J Am Coll Cardiol. 2004 Jun 16;43(12):2219-24.

PMID:
15193683
[PubMed - indexed for MEDLINE]
Free Article
5.

Risk factors for coronary artery disease in patients with elevated high-density lipoprotein cholesterol.

DeFaria Yeh D, Freeman MW, Meigs JB, Grant RW.

Am J Cardiol. 2007 Jan 1;99(1):1-4. Epub 2006 Nov 2.

PMID:
17196452
[PubMed - indexed for MEDLINE]
6.

Usefulness of atherogenic dyslipidemia for predicting cardiovascular risk in patients with angiographically defined coronary artery disease.

Arca M, Montali A, Valiante S, Campagna F, Pigna G, Paoletti V, Antonini R, BarillĂ  F, Tanzilli G, Vestri A, Gaudio C.

Am J Cardiol. 2007 Nov 15;100(10):1511-6. Epub 2007 Oct 4.

PMID:
17996510
[PubMed - indexed for MEDLINE]
7.

Treatment with atorvastatin to the National Cholesterol Educational Program goal versus 'usual' care in secondary coronary heart disease prevention. The GREek Atorvastatin and Coronary-heart-disease Evaluation (GREACE) study.

Athyros VG, Papageorgiou AA, Mercouris BR, Athyrou VV, Symeonidis AN, Basayannis EO, Demitriadis DS, Kontopoulos AG.

Curr Med Res Opin. 2002;18(4):220-8.

PMID:
12201623
[PubMed - indexed for MEDLINE]
8.

Impact of triglyceride levels beyond low-density lipoprotein cholesterol after acute coronary syndrome in the PROVE IT-TIMI 22 trial.

Miller M, Cannon CP, Murphy SA, Qin J, Ray KK, Braunwald E; PROVE IT-TIMI 22 Investigators.

J Am Coll Cardiol. 2008 Feb 19;51(7):724-30. doi: 10.1016/j.jacc.2007.10.038.

PMID:
18279736
[PubMed - indexed for MEDLINE]
Free Article
9.

Comparison of remnant-like lipoprotein particles in postmenopausal women with and without coronary artery disease and in men with coronary artery disease.

Fukushima H, Kugiyama K, Sugiyama S, Honda O, Koide S, Nakamura S, Kawano H, Soejima H, Miyamoto S, Yoshimura M, Sakamoto T, Ogawa H.

Am J Cardiol. 2001 Dec 15;88(12):1370-3.

PMID:
11741554
[PubMed - indexed for MEDLINE]
10.
11.

Plasma triglycerides and type III hyperlipidemia are independently associated with premature familial coronary artery disease.

Hopkins PN, Wu LL, Hunt SC, Brinton EA.

J Am Coll Cardiol. 2005 Apr 5;45(7):1003-12.

PMID:
15808755
[PubMed - indexed for MEDLINE]
Free Article
12.

Comparative effects of 10-mg versus 80-mg Atorvastatin on high-sensitivity C-reactive protein in patients with stable coronary artery disease: results of the CAP (Comparative Atorvastatin Pleiotropic effects) study.

Bonnet J, McPherson R, Tedgui A, Simoneau D, Nozza A, Martineau P, Davignon J; CAP Investigators.

Clin Ther. 2008 Dec;30(12):2298-313. doi: 10.1016/j.clinthera.2008.12.023.

PMID:
19167589
[PubMed - indexed for MEDLINE]
13.

Relation of clinical benefit of raising high-density lipoprotein cholesterol to serum levels of low-density lipoprotein cholesterol in patients with coronary heart disease (from the Bezafibrate Infarction Prevention Trial).

Goldenberg I, Benderly M, Sidi R, Boyko V, Tenenbaum A, Tanne D, Behar S.

Am J Cardiol. 2009 Jan 1;103(1):41-5. doi: 10.1016/j.amjcard.2008.08.033. Epub 2008 Oct 10.

PMID:
19101227
[PubMed - indexed for MEDLINE]
14.

Risk factors that discriminate 'high- risk' from 'low-risk' Japanese patients with coronary artery disease.

Miwa K, Nakagawa K.

Jpn Circ J. 2000 Nov;64(11):825-30.

PMID:
11110425
[PubMed - indexed for MEDLINE]
Free Article
15.

A tertiary care hospital-based study of conventional risk factors including lipid profile in proven coronary artery disease.

Goel PK, Bharti BB, Pandey CM, Singh U, Tewari S, Kapoor A, Garg N, Sinha N.

Indian Heart J. 2003 May-Jun;55(3):234-40.

PMID:
14560932
[PubMed - indexed for MEDLINE]
16.

[Role of small dense low-density lipoprotein in coronary artery disease patients with normal plasma cholesterol levels].

Koba S, Hirano T, Sakaue T, Sakai K, Kondo T, Yorozuya M, Suzuki H, Murakami M, Katagiri T.

J Cardiol. 2000 Dec;36(6):371-8. Japanese.

PMID:
11190580
[PubMed - indexed for MEDLINE]
17.

Relationship between lipid levels and clinical outcomes in the Long-term Intervention with Pravastatin in Ischemic Disease (LIPID) Trial: to what extent is the reduction in coronary events with pravastatin explained by on-study lipid levels?

Simes RJ, Marschner IC, Hunt D, Colquhoun D, Sullivan D, Stewart RA, Hague W, Keech A, Thompson P, White H, Shaw J, Tonkin A; LIPID Study Investigators.

Circulation. 2002 Mar 12;105(10):1162-9.

PMID:
11889008
[PubMed - indexed for MEDLINE]
Free Article
18.

Determinants of serum HDL-C level in a Tehran urban population: the Tehran Lipid and Glucose Study.

Azizi F, Raiszadeh F, Salehi P, Rahmani M, Emami H, Ghanbarian A, Hajipour R.

Nutr Metab Cardiovasc Dis. 2002 Apr;12(2):80-9.

PMID:
12189907
[PubMed - indexed for MEDLINE]
19.

Lipoproteina(a) is a feature of the presence, diffuseness, and severity of coronary artery disease in Saudi population.

Habib SS, Abdel-Gader AM, Kurdi MI, Al-Aseri Z, Soliman MM.

Saudi Med J. 2009 Mar;30(3):346-52.

PMID:
19271061
[PubMed - indexed for MEDLINE]
20.

LDL-C goal attainment among patients newly diagnosed with coronary heart disease or diabetes in a commercial HMO.

Nag SS, Daniel GW, Bullano MF, Kamal-Bahl S, Sajjan SG, Hu H, Alexander C.

J Manag Care Pharm. 2007 Oct;13(8):652-63.

PMID:
17970603
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk